| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Beth C. Seidenberg | Director | 2025-12-18 | 133,333 | $7.50 | $1,000.00kBuy |
| Westlake Biopartners Opportunity Fund I LP | 10% Owner | 2025-12-18 | 133,333 | $7.50 | $1,000.00kBuy |
| Karen Marie Walker | Chief Technology Officer | 2025-12-15 | 23,998 | $4.83 | $115.91kBuy |
| Karen Marie Walker | Chief Technology Officer | 2025-12-15 | 23,998 | $12.20 | $292.78kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vida Ventures LLC | 7.90% | 4,777,060 | $42.37M | Insider |
| Fred E. Cohen | 7.51% | 4,540,558 | $40.27M | Insider |
| Gordonmd Global Investments LP | 7.27% | 4,391,818 | $38.96M | Institution |
| Gilead Sciences Inc | 6.83% | 4,126,119 | $36.60M | Insider |
| Gilead Sciences Inc | 6.83% | 4,126,119 | $36.60M | Institution |
| Beth C. Seidenberg | 6.29% | 3,804,574 | $33.75M | Insider |
| Westlake Biopartners Opportunity Fund I LP | 6.27% | 3,787,940 | $33.60M | Insider |
| Northpond Ventures III GP LLC | 5.39% | 3,255,426 | $28.88M | Insider |
| Bain Capital Life Sciences Investors LLC | 5.23% | 3,163,868 | $28.06M | Insider |
| Bain Capital Life Sciences Investors LLC | 5.15% | 3,110,000 | $27.59M | Institution |